Falls Associate with Neurodegenerative Changes in ATN Framework of Alzheimer’s Disease

Manuscript Number: 

20-0192R1

Author(s): 
Beau M. Ances, Tammie LS Benzinger, Rebecca M. Bollinger, Elizabeth A. Grant, Audrey Keleman, John C. Morris, Susan L. Stark, Julie K. Wisch

Disclosures

Beau M. Ances

  • Nothing to Disclose

Tammie LS Benzinger

  • Consulting Fees:
    Unpaid consulting: Siemens. Unpaid advisory board: Eisai.
    Lecture Fees:
    Biogen
    Grants
    • Agency: 
      Avid Radiopharmaceuticals (Eli Lilly)
      Dates: 
      2015 - present
    • Agency: 
      DIAN Pharma Consortium
      Dates: 
      2010 - Present

Rebecca M. Bollinger

  • Nothing to Disclose

Elizabeth A. Grant

  • Nothing to Disclose

Audrey Keleman

  • Nothing to Disclose

John C. Morris

  • Nothing to Disclose

Susan L. Stark

  • Nothing to Disclose

Julie K. Wisch

  • Nothing to Disclose